Neuro-Bio gives farewell to Georgia Price, Tumisang Moswete and Mark Butler and wishes them all the best for their future. Neuro-Bio is looking forward to welcome Kashif Mahfooz, Sanskar Ranglani, Tom Seymour, Jack Gordon and Nathalia Medina to the team....
Neuro-Bio Ltd welcomes Javier Audibert as new Finance Manager. Javier is a graduate in Law from Complutense University of Madrid and he holds a Master’s degree in corporate finance & law from ESADE Business School. His early career started as Financial...
Neuro-Bio would like to congratulate Rosie Barnett on her graduation. Rosie was a junior research scientist at Neuro-Bio during her industrial placement and she has now graduated with a first class degree in pharmacology. Neuro-Bio wishes Rosie the best of luck for...
Neuro-Bio’s CEO, Susan Greenfield, had a very personal and interesting interview for the Australian Financial Review. Click the link to read the full article.
During the EAN 2022 Annual Congress, Neuro-Bio’s CEO Susan Greenfield participated at the 8th edition of Challenges for women in neurology. She closed the networking event with a lecture about her journey within neuroscience as a woman. To read more...
Neuro-Bio Ltd welcomes Joanna Komorowska as new intern. Joanna is a third-year student of Neuroscience with Psychology at the University of Aberdeen, originally from Poland. She is interested in neurogenerative diseases and how they affect the human body and mind. For...
Neuro-Bio Ltd welcomes Amy-May Pointer as new Laboratory Manager. Amy-May graduated from the University of Nottingham with a Bachelor Honours degree in Microbiology. Her final-year research project focused on Extended-Spectrum Beta-Lactamases (ESBL) Producing...
Neuro-Bio’s paper has been published on “International Journal of Biochemistry and Cell Biology” with the title WHEN A TROPHIC PROCESS TURNS TOXIC: ALZHEIMER’S DISEASE AS AN ABERRANT RECAPITULATION OF A DEVELOPMENTAL MECHANISM. Garcia-Ratés,...
Susan Greenfield, Founder and CEO of Neuro-Bio Ltd, shared her insights on the challenges of developing Alzheimer’s disease treatments, and the fundamental flaw with approaches to date on the “European Biopharmaceutical Review”. To read the full article,...
On Saturday the 25th of June, Neuro-Bio’s CEO Susan Greenfield, will speak at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be “Where Neuroscience meets neurology: blowing, expanding, and losing the...
